Literature DB >> 11269982

Diabetic retinopathy.

J S Wong1, L P Aiello.   

Abstract

INTRODUCTION: To provide a review of the current standard of care in diabetic eye management.
METHODS: A non-systematic evidence-based review utilising available data and consensus statements on the subject matter.
RESULTS: Diabetes mellitus affects some 9.0% of Singaporeans, and more than 60% of patients with diabetes in this population remained undiagnosed. Diabetic retinopathy is an important complication among diabetic patients and adverse visual outcome associated with this condition can be reduced by more than 95% by taking measures including good glycaemic control, timely and appropriate laser therapy, and vitrectomy surgery when indicated. An important aspect of management is the accurate disease classification which is essential for prognostication, appropriate follow-up schedule, and timing of therapeutic intervention purposes.
CONCLUSION: Diabetic retinopathy will remain a significant problem if the current trend in diabetes among Singapore residents prevails. As the severe visual impairment associated with diabetic retinopathy can be largely prevented with appropriate and timely intervention, the major challenge to the health care providers today is the identification and education of patients with diabetes, and the enrollment of these patients in a life-long comprehensive ophthalmic management programme in order to minimise visual morbidity.

Entities:  

Mesh:

Year:  2000        PMID: 11269982

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  2 in total

1.  Expression of Long Non-Coding RNA (lncRNA) SNHG5 in Patients with Refractory Diabetic Macular Edema and Its Regulatory Mechanism.

Authors:  Junwen He; Zhang Rui; Jing Gao; Yanhong Chen; Yanzi Li; Tao Xu; Shan Wang
Journal:  Med Sci Monit       Date:  2022-01-10

2.  Microglia enhanced the angiogenesis, migration and proliferation of co-cultured RMECs.

Authors:  Xinyi Ding; Ruiping Gu; Meng Zhang; Hui Ren; Qinmeng Shu; Gezhi Xu; Haixiang Wu
Journal:  BMC Ophthalmol       Date:  2018-09-17       Impact factor: 2.209

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.